{"transactions":[{"id":906039,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2026-02-13T18:16:25.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4964,"derivative":{"underlying":"Common Stock","underlying_shares":860},"source":{"system":"sec-edgar","filing":"0000920148-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000090/form4.xml","form_type":"4"}},{"id":906038,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2026-02-13T18:16:25.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":245,"price":289.89,"value":71023.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":1817.239,"source":{"system":"sec-edgar","filing":"0000920148-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000090/form4.xml","form_type":"4"}},{"id":906037,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2026-02-13T18:16:25.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":860,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."}],"balance_after":2062.239,"source":{"system":"sec-edgar","filing":"0000920148-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000090/form4.xml","form_type":"4"}},{"id":908485,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2026-02-12T20:41:51.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":2350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":5824,"derivative":{"underlying":"Common Stock","underlying_shares":2350},"source":{"system":"sec-edgar","filing":"0000920148-26-000066","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000066/form4.xml","form_type":"4"}},{"id":908484,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Non-qualified Stock Options","published_at":"2026-02-12T20:41:51.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":7100,"derivative":{"exercise_price":284.5,"exercise_date":"2027-02-10","expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0000920148-26-000066","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000066/form4.xml","form_type":"4"}},{"id":912950,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T20:34:20.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":3474,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0000920148-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000036/form4.xml","form_type":"4"}},{"id":912949,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2026-02-10T20:34:20.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":254,"price":277.2,"value":70408.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":1202.239,"source":{"system":"sec-edgar","filing":"0000920148-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000036/form4.xml","form_type":"4"}},{"id":912948,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2026-02-10T20:34:20.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":893,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."}],"balance_after":1456.239,"source":{"system":"sec-edgar","filing":"0000920148-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000036/form4.xml","form_type":"4"}},{"id":1270209,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2025-02-13T16:18:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":2580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":4367,"derivative":{"underlying":"Common Stock","underlying_shares":2580},"source":{"system":"sec-edgar","filing":"0001127602-25-004529","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004529/form4.xml","form_type":"4"}},{"id":1270208,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Non-qualified Stock Options","published_at":"2025-02-13T16:18:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":7800,"derivative":{"exercise_price":245.14,"exercise_date":"2026-02-11","expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001127602-25-004529","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225004529/form4.xml","form_type":"4"}},{"id":1277255,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T14:00:11.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":false,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number reflects the aggregate number of Restricted Stock Units held by the reporting person."}],"balance_after":1787,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0001127602-25-003711","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003711/form4.xml","form_type":"4"}},{"id":1277254,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2025-02-10T14:00:11.000Z","date":"2025-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":336,"price":247.74,"value":83240.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock withholding to satisfy tax withholding obligations."}],"balance_after":557,"source":{"system":"sec-edgar","filing":"0001127602-25-003711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003711/form4.xml","form_type":"4"}},{"id":1277253,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Common Stock","published_at":"2025-02-10T14:00:11.000Z","date":"2025-02-06","kind":"exercise","planned":false,"acquired":true,"shares":893,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."}],"balance_after":893,"source":{"system":"sec-edgar","filing":"0001127602-25-003711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760225003711/form4.xml","form_type":"4"}},{"id":1343709,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Restricted Stock Unit","published_at":"2024-12-04T15:05:22.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":2680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units vest in three equal annual installments beginning on February 6, 2025."}],"balance_after":2680,"derivative":{"underlying":"Common Stock","underlying_shares":2680},"source":{"system":"sec-edgar","filing":"0001127602-24-028581","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224028581/form4.xml","form_type":"4"}},{"id":1343708,"issuer":{"id":1277,"kind":"organization","name":"LABCORP HOLDINGS INC.","symbol":"LH"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"officer":true,"officer_title":"Chief Financial Officer, EVP"}}],"security":"Non-qualified Stock Options","published_at":"2024-12-04T15:05:22.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on the date reflected in this column."}],"balance_after":8100,"derivative":{"exercise_price":240.63,"exercise_date":"2025-02-06","expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001127602-24-028581","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920148/000112760224028581/form4.xml","form_type":"4"}},{"id":1460325,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-07-03T17:05:32.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":472,"price":143.8955,"value":67918.676,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.8513 to $144.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000080","document":"wk-form4_1720040726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000080/wk-form4_1720040726.xml","form_type":"4"}},{"id":1468809,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-06-26T17:26:00.000Z","date":"2024-06-24","kind":"sale","planned":false,"acquired":false,"shares":899,"price":155.66,"value":139938.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000079","document":"wk-form4_1719437152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000079/wk-form4_1719437152.xml","form_type":"4"}},{"id":1473374,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-06-20T17:26:27.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":314,"price":159.7408,"value":50158.6112,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.12 to $159.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000074","document":"wk-form4_1718918780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000074/wk-form4_1718918780.xml","form_type":"4"}},{"id":1473373,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-06-20T17:26:27.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":253,"price":158.9981,"value":40226.5193,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.885 to $159.2191, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":314,"source":{"system":"sec-edgar","filing":"0001651308-24-000074","document":"wk-form4_1718918780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000074/wk-form4_1718918780.xml","form_type":"4"}},{"id":1473372,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-06-20T17:26:27.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":195,"price":158.5843,"value":30923.9385,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.40 to $160.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":567,"source":{"system":"sec-edgar","filing":"0001651308-24-000074","document":"wk-form4_1718918780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000074/wk-form4_1718918780.xml","form_type":"4"}},{"id":1473371,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-06-20T17:26:27.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":154,"price":158.2368,"value":24368.4672,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.10 to $159.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":762,"source":{"system":"sec-edgar","filing":"0001651308-24-000074","document":"wk-form4_1718918780.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000074/wk-form4_1718918780.xml","form_type":"4"}},{"id":1487086,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-07T16:54:31.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":256659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":256659,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":256659},"source":{"system":"sec-edgar","filing":"0001651308-24-000056","document":"wk-form4_1717793661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000056/wk-form4_1717793661.xml","form_type":"4"}},{"id":1487085,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-06-07T16:54:31.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":136240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":456326,"source":{"system":"sec-edgar","filing":"0001651308-24-000056","document":"wk-form4_1717793661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000056/wk-form4_1717793661.xml","form_type":"4"}},{"id":1603517,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2024-03-04T17:22:09.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":397,"price":167.08,"value":66330.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-24-000016","document":"wk-form4_1709590911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130824000016/wk-form4_1709590911.xml","form_type":"4"}},{"id":1834107,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2023-07-06T17:02:07.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":472,"price":179.5495,"value":84747.364,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.5185 to $179.665, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-23-000104","document":"wf-form4_168867731225214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000104/wf-form4_168867731225214.xml","form_type":"4"}},{"id":1843548,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2023-06-27T17:22:38.000Z","date":"2023-06-23","kind":"sale","planned":false,"acquired":false,"shares":840,"price":182.85,"value":153594.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-23-000102","document":"wf-form4_168790094090281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000102/wf-form4_168790094090281.xml","form_type":"4"}},{"id":1849842,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-20T18:51:07.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":409058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F5","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":409058,"derivative":{"exercise_price":16.41,"expiration_date":"2033-06-14","underlying":"Ordinary Shares","underlying_shares":409058},"source":{"system":"sec-edgar","filing":"0001651308-23-000091","document":"wf-form4_168730145579147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000091/wf-form4_168730145579147.xml","form_type":"4"}},{"id":1849841,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2023-06-20T18:51:07.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":190,"price":192.5421,"value":36582.999,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.50 to $192.58, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-23-000091","document":"wf-form4_168730145579147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000091/wf-form4_168730145579147.xml","form_type":"4"}},{"id":1849840,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-06-20T18:51:07.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":107770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":342303,"source":{"system":"sec-edgar","filing":"0001651308-23-000091","document":"wf-form4_168730145579147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000091/wf-form4_168730145579147.xml","form_type":"4"}},{"id":1974583,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2023-03-03T17:00:58.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":343,"price":240.2096,"value":82391.8928,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.195 to $240.245, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-23-000037","document":"wf-form4_167788080268388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130823000037/wf-form4_167788080268388.xml","form_type":"4"}},{"id":2206354,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2022-07-18T17:22:14.000Z","date":"2022-07-01","kind":"sale","acquired":false,"shares":317,"price":158.5,"value":50244.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on July 1, 2022 as a total of 295 American Depositary Shares (\"ADSs\") sold when in fact 317 ADSs were sold. As a result of this administrative error, the number of Ordinary Shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of Ordinary Shares reported as beneficially owned by the reporting person by 286 Ordinary Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-22-000125","document":"wf-form4a_165817931742680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000125/wf-form4a_165817931742680.xml","form_type":"4/A","original_submission_date":"2022-07-05"}},{"id":2214987,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2022-07-05T17:29:11.000Z","date":"2022-07-01","kind":"sale","acquired":false,"shares":295,"price":158.5,"value":46757.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-22-000119","document":"wf-form4_165705652132138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000119/wf-form4_165705652132138.xml","form_type":"4"}},{"id":2222196,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-24T17:40:01.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":589888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":589888,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":589888},"source":{"system":"sec-edgar","filing":"0001651308-22-000112","document":"wf-form4_165610678473488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000112/wf-form4_165610678473488.xml","form_type":"4"}},{"id":2222195,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-06-24T17:40:01.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":245583,"source":{"system":"sec-edgar","filing":"0001651308-22-000112","document":"wf-form4_165610678473488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000112/wf-form4_165610678473488.xml","form_type":"4"}},{"id":2225699,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2022-06-21T17:09:28.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":161,"price":136.6393,"value":21998.9273,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-22-000084","document":"wf-form4_165584573671205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000084/wf-form4_165584573671205.xml","form_type":"4"}},{"id":2361305,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-02T17:12:42.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":61750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,677 ordinary shares acquired pursuant to the Company's Second Amended and Restated 2018 Employee Share Purchase Plan."}],"balance_after":143299,"source":{"system":"sec-edgar","filing":"0001651308-22-000035","document":"wf-form4_164625910284672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130822000035/wf-form4_164625910284672.xml","form_type":"4"}},{"id":2648082,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":66570,"kind":"person","name":"Wang Julia Aijun","position":1,"cik":"0001860279","reported_name":"Wang Julia Aijun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"American Depositary Shares","published_at":"2021-07-01T16:58:07.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":308,"price":349.0639,"value":107511.6812,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.9264 to $349.35, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000147","document":"wf-form4_162517305797222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860279/000165130821000147/wf-form4_162517305797222.xml","form_type":"4"}}]}